| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 59 |
| 1 | CYCLOPHOSPHAMIDE | 21 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 21 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 21 |
| 4 | METHOTREXATE SODIUM | 21 |
| 5 | METHOTREXATE | 20 |
| 6 | ETOPOSIDE | 18 |
| 7 | OCRELIZUMAB | 18 |
| 8 | DEXAMETHASONE | 17 |
| 9 | DEXAMETHASONE 1.5 MG | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IFOSFAMIDE FOR INJECTION | 16 | 0.0007 |
| 1 | CARMUSTINE | 3 | 0.0006 |
| 2 | OBINUTUZUMAB | 9 | 0.0005 |
| 3 | OCRELIZUMAB | 18 | 0.0003 |
| 4 | RITUXIMAB | 59 | 0.0003 |
| 5 | ETOPOSIDE | 18 | 0.0002 |
| 6 | MELPHALAN HYDROCHLORIDE | 6 | 0.0002 |
| 7 | CYTARABINE | 13 | 0.0002 |
| 8 | OFATUMUMAB | 7 | 0.0002 |
| 9 | DEXAMETHASONE SODIUM PHOSPHATE | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 92 | 0.0003 |
| 1 | Topoisomerase Inhibitor [EPC] | 18 | 0.0002 |
| 2 | Penem Antibacterial [EPC] | 6 | 0.0002 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 31 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 6 | BCL-2 Inhibitor [EPC] | 5 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 15 | 0.0001 |
| 8 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 13 | 0.0000 |